Emerging competitive pressure is also building from smaller biotechnology firms developing next-generation dual and triple agonist molecules, positioning the market for intensified competition as new mechanisms of action and delivery formats advance through late-stage clinical development in the coming years
There are no dietary restrictions with this doctor-backed, personalized weight loss program
The FDA stopped pharmacies from selling compounded tirzepatide after confirming that the manufacturer of Mounjaro and Zepbound could meet the rising demand for the drug
GLP-1s open a door, but lasting health comes from how we walk through it guided by sleep, calm, purpose, and connection. Dive into our GLP-1 resource center for stories on weight loss, medications, side effects, and more
For researchers managing multiple compounds, an organized inventory system prevents waste from forgotten or expired stock
STEP-1 followed 1,961 adults on weekly semaglutide for 68 weeks, and SURMOUNT-1 followed 2,539 adults on tirzepatide for 72 weeks